/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Biomea Fusion, Inc.

Biomea Fusion, Inc.

Company

The company creates novel covalent small molecules to treat serious and life-threatening diseases.

Healthcare & Biotech

Biomea Fusion, Inc. has 2 investors on file, among them Aisling Capital and Boxer Capital. Its site was last checked 6 Nov 2026: site answers.

biomeafusion.com

Investors

2 investors on file
InvestorEvidenceType
Aisling CapitalPortfolio pageVenture capital
Boxer CapitalPortfolio pageVenture capital

In the news

1 headline naming Biomea Fusion, Inc.
Biomea Fusion Announces Poster Presentation of Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist, at ObesityWeek® 2026manilatimes.netProduct

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from Aisling Capital

68 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (92%), Fintech (3%), Industrial & Manufacturing (2%).

Aclaris TherapeuticsAclaris Therapeutics is a biopharmaceutical company that strives to tr…AgileAgile Therapeutics develops and commercializes women's healthcare prod…Ambit Biosciences CorporationAmbit Biosciences Corporation is a biopharmaceutical company focused o…Antios TherapeuticsAntios Therapeutics develops innovative therapies to treat and cure he…Arcus Biosciences, Inc.Arcus Biosciences creates medicines by advancing validated biology wit…

See Aisling Capital's full profile · Who invests alongside it

More from Boxer Capital

40 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (90%), AI & Machine Learning (5%), Fintech (3%).

Aligos TherapeuticsAligos Therapeutics develops therapies for liver and viral diseasesAvidity BiosciencesAvidity Biosciences is developing RNA therapeutics for rare muscle dis…BioAtlaBioAtla develops novel therapeutics with improved therapeutic index th…Boundless BioBoundless Bio develops therapies for patients with intractable oncogen…Cabaletta BioCabaletta Bio develops T cell therapies to treat autoimmune diseases

See Boxer Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Biomea Fusion, Inc. and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Aisling Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/biomeafusion.com/investors

# also
GET /v1/companies/biomeafusion.com
GET /v1/companies/biomeafusion.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing